Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Maastricht University Medical Center
With
Academic Community Mental Health Centre (RIAGG)
A single-case series design with multiple randomized baselines across participants will be used in this study. The study will last approximately 36 months and comprises three phases. The first phase is a 6-12 weeks waiting list/baseline phase during which participants will be repeatedly assessed with the main outcome measures and putative mediators. In the second phase participants will receive up to 75 individual sessions of SFT for chronic depression depending on the individual progress in therapy. Upon completion of the intervention phase, participants will have monthly follow-up assessments for the next 12 months.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Chronic MDD as defined by the DSM-IV (meeting full criteria of MDD for at least 2 years).
Beck Depression Inventory II (BDI-II) score at screening \>=20 (moderate to severe depression)
Can understand and speak the Dutch language
Has internet access at home
You may not be if
Acute suicide risk
Substance induced mood disorder
Medical condition causes depression directly or through medication intake
Started with antidepressant medication within three months prior to initial screening. Patients who receive antidepressant medication for more than 3 months prior to the start of the study can keep taking their medication and will not be excluded from participation.
MRI contra-indications, such as claustrophobia, metal parts in the body and, for women, current pregnancy or breastfeeding.
